|
ACOX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71209999999533E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.69149999998497E-06 |
| Normal-vs-Stage2 |
5.049000E-04 |
| Normal-vs-Stage3 |
2.6865000002374E-07 |
| Normal-vs-Stage4 |
1.79910000008832E-07 |
| Stage1-vs-Stage2 |
8.842200E-01 |
| Stage1-vs-Stage3 |
1.349420E-01 |
| Stage1-vs-Stage4 |
1.183990E-01 |
| Stage2-vs-Stage3 |
2.381400E-01 |
| Stage2-vs-Stage4 |
9.977800E-02 |
| Stage3-vs-Stage4 |
5.197600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2476000000049E-06 |
| Normal-vs-AfricanAmerican |
2.24120000003047E-07 |
| Normal-vs-Asian |
1.546200E-02 |
| Caucasian-vs-AfricanAmerican |
9.602100E-02 |
| Caucasian-vs-Asian |
8.450600E-01 |
| AfricanAmerican-vs-Asian |
7.123800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21890000004399E-06 |
| Normal-vs-Female |
3.74279999992844E-07 |
| Male-vs-Female |
3.752000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.05019999994272E-07 |
| Normal-vs-Extreme_Weight |
2.06619999998381E-07 |
| Normal-vs-Obese |
1.05090000035446E-07 |
| Normal-vs-Extreme_Obese |
2.867800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.642600E-01 |
| Normal_Weight-vs-Obese |
5.546800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.814450E-01 |
| Extreme_Weight-vs-Obese |
2.990200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.295400E-01 |
| Obese-vs-Extreme_Obese |
3.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.46069999999543E-05 |
| Normal-vs-Age(41-60Yrs) |
2.18249999999198E-05 |
| Normal-vs-Age(61-80Yrs) |
4.38040000050322E-07 |
| Normal-vs-Age(81-100Yrs) |
1.20870000008821E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.272800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.938200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.031000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.959500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.255100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.483820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.23809999999602E-06 |
| Normal-VS-Type2 PRCC |
1.6442000000394E-06 |
| Normal-VS-KIRP CIMP |
1.05999999999717E-07 |
| Normal-VS-Unclassified PRCC |
2.42619999999416E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.256000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.679800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.661800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.214200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.466800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.477600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.48019999987892E-07 |
| Normal-vs-N1 |
6.84089995761639E-09 |
| Normal-vs-N2 |
1.870260E-02 |
| N0-vs-N1 |
3.074100E-02 |
| N0-vs-N2 |
5.943200E-01 |
| N1-vs-N2 |
6.946200E-01 |
|
|
